Honvo, Germain http://orcid.org/0000-0002-6992-6712
Reginster, Jean-Yves http://orcid.org/0000-0001-6290-752X
Rannou, Francois
Rygaert, Xavier
Geerinck, Anton
Rabenda, Véronique
McAlindon, Tim
Charles, Alexia
Fuggle, Nicholas
Cooper, Cyrus
Curtis, Elizabeth
Arden, Nigel
Avouac, Bernard
Bruyère, Olivier http://orcid.org/0000-0003-4269-9393
Article History
First Online: 9 May 2019
Compliance with Ethical Standards
: All authors meet the International Committee of Medical Journal Editors (ICMJE) criteria for authorship for this manuscript, take responsibility for the integrity of the work as a whole, and have given final approval to the version to be published.
: G. Honvo was funded by the ESCEO, a Belgian not-for-profit organization. The ESCEO Working Group was entirely funded by the ESCEO. The ESCEO receives unrestricted educational grants, to support its educational and scientific activities, from non-governmental organizations, not-for-profit organizations, non-commercial and corporate partners. The choice of topics, participants, content and agenda of the working groups as well as the writing, editing, submission and reviewing of the manuscript are under the sole responsibility of the ESCEO, without any influence from third parties.
: O. Bruyère reports grants from Biophytis, IBSA, MEDA, Servier, SMB, and Theramex, outside of the submitted work. C. Cooper reports personal fees from Alliance for Better Bone Health, Amgen, Eli Lilly, GSK, Medtronic, Merck, Novartis, Pfizer, Roche, Servier, Takeda and UCB, outside of the submitted work. J.-Y. Reginster reports grants from IBSA-Genevrier, Mylan, CNIEL, and Radius Health (through institution); consulting fees from IBSA-Genevrier, Mylan, CNIEL, Radius Health, and Pierre Fabre; fees for participation in review activities from IBSA-Genevrier, Mylan, CNIEL, Radius Health, and Teva; payment for lectures from AgNovos, CERIN, CNIEL, Dairy Research Council (DRC), Echolight, IBSA-Genevrier, Mylan, Pfizer Consumer Health, Teva, and Theramex, outside of the submitted work. B. Avouac reports consulting fees from Novartis, BMS, Roche, Janssen Cilag, Expanscience, and IRIS, and fees for participating in research activities from Sanofi, Amgen, Takeda, Allegan, AbbVie, Vertex, AstraZeneca, Ipsen, Leadiant, Otsuka, Jazz, Leo and Alexion, outside of the submitted work. E. Curtis reports lecture fees and travel support from Eli Lilly, Pfizer and UCB, outside of the submitted work. N. Fuggle reports travel support from Eli Lilly and Pfizer, outside of the submitted work. N. Arden reports personal fees from Bioventus, Flexion, Merck, Pfizer/Lilly, Regeneron, Smith & Nephew, and Freshfields Bruckhaus Deringer and grants from Bioiberica and Merck, outside the submitted work. F. Rannou reports grants from APHP, INSERM, University Paris Descartes, and Arthritis (Road Network), and consulting fees from Pierre Fabre, Expanscience, Thuasne, Servier, Genevrier, Sanofi Aventis, and Genzyme, outside of the submitted work. T. McAlindon reports fees for participation in review activities from Pfizer and fees for consulting activities with Flexion, Samumed, Sanofi, Visgo, Roche, Astellas, Pfizer, Seikayaku, Regeneron, and Anika, outside of the submitted work. G. Honvo, X. Rygaert, A. Geerinck, V. Rabenda and A. Charles report nothing to disclose.